I joined the pathway discovery group at Biogen in June 2013, where my research interests include neurodegeneration, with a special emphasis on Parkinson’s disease (PD) and aymotrophic lateral sclerosis (ALS), two devastating neurodegenerative diseases effecting dopaminergic and motor neurons respectively. I received my Ph.D. from Tata Institute of Fundamental Research, Mumbai, India, where my graduate work in the lab of Professor Veronica Rodrigues focused on neuronal fate choice and target specification. I went on to Columbia University, New York, and Harvard Medical School, Boston, where I completed my postdoctoral training. In the Artavanis-Tsakonas lab at Harvard, I worked on developing Drosophila models of neurodegeneration with an aim to develop a target discovery platform for neurodegenerative diseases including spinal muscular atrophy, ALS, and PD by combining in silico approaches with high-throughput in vivo validation in Drosophila.

Education

  • Ph.D., Tata Institute of Fundamental Research, Mumbai University, Mumbai, India - 2005
  • M.S., Biotechnology, Banaras Hindu University, Varanasi, India - 1998
  • B.Sc., Presidency College, Calcutta University, Kolkata, India - 1996

Selected Publications

See more scientists